In eukaryotes, the Mediator complex has important roles in regulation of transcription by RNA polymerase II. Mediator is a large complex with more than 20 subunits that form head, middle, tail and CDK/cyclin modules. Among them, CDK8 and/or CDK19 (CDK8/19), and their counterpart cyclin C, form the CDK/cyclin module together with Mediator subunits MED12 and MED13. Despite evidences of both activation and repression, the precise functional roles of CDK8/19 in transcription are still elusive. Our previous results indicate that CDK8/19 recruits epigenetic regulators to repress immunoresponse genes. Here, this study focused on Toll-like receptors (TLRs), which exert innate immune responses through recognition of pathogen-associated molecular patterns and examined the functional roles of CDK8/ 19. As a result, CDK8/19 regulated transcription of inflammatory genes on stimulation of TLR9 in myeloma-derived RPMI8226 cells, which led to expression of inflammation-associated genes such as IL8, IL10, PTX3 and CCL2. Mediator subunits CDK8/19 and MED1, inflammation-related transcriptional activator NF-jB and C/EBPb, and general transcription factors TFIIE and TFIIB colocalized at the promoter regions of these genes under this condition. Our results show that CDK8/19 positively regulates inflammatory gene transcription in cooperation with NF-jB and C/EBPb on stimulation of TLR9.
Introduction
In eukaryotes, mRNA transcription is strictly regulated via conformational changes of chromatin in the nucleus (Lee & Young 2000; Li et al. 2007; Malik & Roeder 2010) . The Mediator complex (Mediator) is central to this regulation and acts by forming a bridge between chromatin and the transcription apparatus. Evidences suggest that Mediator functions in host defense, maintenance of homeostasis and cell differentiation in response to various extracellular signals.
In humans, Mediator consists of approximately 30 subunits: 28 MED subunits including their paralogs, MED1-like (MED1L), MED12-like (MED12L) and MED13-like (MED13L), as well as two cyclindependent kinase (CDK) subunits (CDK8 and its paralog CDK19) and their common counterpart cyclin C (Bourbon et al. 2004; Conaway et al. 2005) . Among them, the CDK/cyclin module including CDK8 or CDK19, cyclin C, MED12 and MED13 has a unique reversible character of both association with and dissociation from the other three (core) Mediator modules . We previously showed that CDK8 and/or CDK19 (CDK8/19) repress transcriptional induction of IL8 and TNF genes by phorbol 12-myristate 13-acetate (PMA) treatment of HeLa cells (Tsutsui et al. 2013) . CDK8/ 19 has been shown to regulate both activation and repression of transcription, but the involvement of CDK8/19 in transcriptional regulation in response to various different forms of extracellular stimulation has not yet been elucidated (Hengartner et al. 1998; Akoulitchev et al. 2000; Liu et al. 2004; Furumoto et al. 2007; Tsutsui et al. 2008; Fukasawa et al. 2012) .
In mammals, cellular reactions to bacterial and viral infections, tissue stresses and injuries are essential for survival and involve activation of Toll-like receptors (TLRs) in hematopoietic cells (Kawai & Akira 2010) . TLRs are conserved in mammals and recognize various pathogens derived from bacteria and viruses, thereby acting to protect hosts against infection. For example, TLR9 recognizes unmethylated CpG DNA sequences, which are abundant in prokaryotic genomes, but rare in eukaryotic genomes; this recognition by TLR9 elicits innate immune responses (Krieg et al. 1995; Hemmi et al. 2000) . TLR9 also recognizes synthetic single-stranded DNA oligonucleotides containing unmethylated CpG sequences, which also activates innate immunity (Hartmann et al. 2000; Bauer et al. 2001; Takeshita et al. 2004) . However, the roles of Mediator in transcriptional regulation in TLR9-mediated inflammatory responses caused by CpG-containing oligonucleotides have not been known.
This study focused on the Mediator kinase subunits CDK8 and CDK19, together with transcription factors NF-jB (nuclear factor j-light-chain enhancer of activated B cells) and C/EBPb (CCAAT/enhancer-binding protein b), which activate transcription of inflammatory cytokines, and evaluated their roles in stimulation of natural immunity by CpGcontaining oligonucleotides via TLR9. Expression of TLRs was measured in three cell lines, and levels of inflammatory cytokines were determined in myeloma-derived RPMI8226 cells after stimulation with oligonucleotides containing CpG or nonstimulatory control GpC sequences, showing that transcription of inflammatory genes was upregulated by stimulation of TLR9. Chromatin immunoprecipitation (ChIP) assays showed colocalization of CDK8/19, NF-jB and C/EBPb at inflammatory gene promoter regions, indicating that CDK8/19 has an important role in the regulation of mRNA expression and activation of innate immune responses.
Results

Myeloma-derived RPMI8226 cells express TLR genes at high levels
Previous reports showed that RPMI8226 cells express TLR1, TLR4, TLR6, TLR7, TLR9 and TLR10 (Krieg et al. 1995) . In this study, the expression levels of human TLR genes (TLR1-10) and GAPDH in HEK293, RPMI8226 and Jurkat cells were measured by reverse-transcription quantitative-PCR (RTqPCR) (Fig. 1) . The cells expressed similar levels of TLR2 mRNA, but RPMI8226 cell showed higher levels of expression of TLR1, TLR4, TLR6, TLR8, TLR9 and TLR10 mRNAs than the other cell types, suggesting that RPMI8226 cell is most useful for studying TLR signaling. And we decided to study TLR9 since this gene showed the highest extent of expression in RPMI8226 cells.
Stimulation of TLR9 with CpG-containing oligonucleotides increases expression of inflammatory cytokines, chemokines and novel inflammatory biomarker mRNAs
The relationship between TLR9 signaling and transcriptional activation of inflammatory genes was studied by treatment of RPMI8226 cells with TLR9-agonistic synthetic phosphorothioate oligonucleotides (ODN) containing unmethylated CpG motifs (ODN2006), which strongly activate B cells through NF-jB signaling (Bauer et al. 2001; Takeshita et al. 2001 Takeshita et al. , 2004 . RPMI8226 and Jurkat cells were stimulated with either ODN2006 or the negative control Figure 1 Relative expression of human Toll-like receptor (hTLR) genes. Relative expression of TLR1-10 mRNA was quantified by RT-qPCR (n = 3), where the endogenous control was GAPDH and the calibration sample was QPCR human reference total RNA.
Genes to Cells (2017) 22, 265-276 (NTC) ODN2006GC (containing a GpC sequence instead of CpG). The expression levels of genes (IL6, IL8, IL10, TNF, PTX3, CXCR4, CXCL2, CCL2, CCL3 and CCL4) encoding major cytokines, chemokines and inflammatory biomarkers were measured using RT-qPCR (Fig. 2) . As a result of TLR9 stimulation with ODN2006, high levels of expression of IL8, IL10, PTX3, CCL2, CCL3 and CCL4 mRNAs were observed in RPMI8226 cells, although these levels were not significantly different from the expression with ODN2006GC treatment (Fig. 2A,C , E,G-I) . Surprisingly, the expression levels of TNF and CXCL2 (which are considered to be downstream of NF-jB signaling), IL6 (which is produced in human B cells on TLR9 stimulation) and CXCR4 (which we previously reported as a CDK8/19-target gene) were not upregulated in RPMI8226 cells, which are derived from peripheral B lymphocytes (Fig. 2B ,D,F,J). Jurkat cells, which do not express TLR9, showed no effects on expression of these cytokine genes upon TLR9 stimulation. These findings suggest that TLR9 signaling is modulated not only through NF-jB, but also through other factors such as transcriptional activators, Mediator and chromatin-remodeling factors.
CDK8/19 positively regulates transcription of inflammatory genes upon TLR9 stimulation As described above, the functional roles and molecular mechanisms of Mediator in transcription remain elusive. Thus, to investigate the roles of CDK8/19 in transcriptional regulation on TLR9 stimulation, expression of CDK8/19 in RPMI8226 was knocked down by treatment with small interfering RNA (siRNA), and mRNA levels of IL8, PTX3, IL10 and CCL2 were measured by RT-qPCR on treatment with ODN2006. CDK8/19 was effectively knocked down at both mRNA and protein levels by siRNA treatment (Fig. 3A,B) . Although CDK8/19 knockdown had little effect on expression of IL8 and CCL2, CDK8 knockdown decreased expression of IL10 and PTX3 more effectively than CDK19 knockdown (Fig. 3C,F 
versus D,E).
CDK8/19, C/EBPb and NF-jB colocalize on inflammatory gene promoter regions NF-jB and C/EBPb are the major transcriptional activators of expression of cytokines and chemokines (Natsuka et al. 1992) . Because our results showed that CDK8/19 regulated inflammatory gene expression, we showed that CDK8/19 might be localized on the cytokine and chemokine gene promoters, activating transcription upon TLR9 stimulation in collaboration with NF-jB and C/ EBPb.
To prove this, ChIP assays were carried out to determine whether CDK8/19, C/EBPb and NF-jB colocalize at the IL8, IL10 and PTX3 promoter regions upon TLR9 stimulation (Fig. 4) . Both CDK8 and CDK19 proteins (CDK8/19) were detected with anti-CDK8 antibody (sc-1521; Santa Cruz Biotechnology, Dallas, TX, USA), which cross-reacts with CDK19 (Tsutsui et al. 2011) . RNA polymerase II (Pol II), C/EBPb, NF-jB and CDK8/19 colocalized on the IL8, IL10 and PTX3 promoter regions in cells treated with ODN2006 (Fig. 4) . The level of binding of each of these proteins was significantly higher than in untreated cells. The results suggest that CDK8/19, C/EBPb and NF-jB are cooperatively recruited to target-gene promoters by TLR9 stimulation, triggering Pol II transcription. Notably, although knockdown of expression of CDK8 and CDK19 had little effect on IL8 expression (Fig. 3C ), CDK8/19 localized on the IL8 promoter (Fig. 4A ). In addition, although protein binding to the promoter regions of these genes was generally higher than to exon sequences, Pol II and CDK8/19 localized on the IL8 exon region as much as the promoter region (Fig. 4A ).
CDK8/19-interacting proteins colocalize on promoters of inflammatory genes CDK8/19 binding was furthermore evaluated by ChIP assay with anti-CDK8, which was raised against recombinant CDK8 in our laboratory and anti-CDK19 antibodies (Figs 5A-C,S1 in Supporting Information). We confirmed each antibody was specific to either recombinant CDK8 or CDK19 by Western blotting (Fig. S1 in Supporting Information). The results suggested that both CDK8 and CDK19 were localized at the promoter regions of the IL8, IL10 and PTX3 genes.
To initiate accurate Pol II transcription, five general transcription factors (TFIIB, TFIID, TFIIE, TFIIF and TFIIH) are essential for forming the transcription pre-initiation complex (PIC). Among them, TFIIB directs Pol II to bind adjacent to the transcription initiation site and TFIIE recruits the other general transcription factor TFIIH to the PIC to complete PIC formation (Ohkuma et al. 1990; Ohkuma & Roeder 1994) . TFIIE consists of two subunits, a and b, and plays essential roles in transcription initiation and the transition from initiation to elongation, whereas CDK8 and Mediator middlemodule subunit MED1 were initially found to activate transcription of thyroid hormone receptordependent genes (Belakavadi & Fondell 2010 ). Thus, CDK8/19 and MED1 were studied whether they locate to the promoter regions of the IL8, IL10 and PTX3 genes on TLR9 stimulation. The localization of TFIIEa and TFIIB was also checked as positive controls of PIC formation ( Fig. 5A-C) . These results suggested that CDK8, CDK19, MED1, TFIIEa and TFIIB all were accumulated on inflammatory gene promoters and have roles in transcriptional activation.
Histone H3K27 modifications are not changed on inflammatory gene promoters on stimulation of TLR9
Previously, we showed that protein arginine N-methyltransferase 5 (PRMT5) symmetrically dimethylates histone H3 arginine 2 (H3R2me2s) to repress C/EBPb-target-gene transcription through interaction with CDK8/19 (Tsutsui et al. 2013) . Furthermore, direct interaction of CDK8/19 with siRNA:
*** *** *** -actin Figure 3 Effects of knockdown of CDK8 and/or CDK19 on IL8, IL10, PTX3 and CCL2. (A) Knockdown efficiencies of si-CDK8 and/or si-CDK19. After siRNA treatment, RPMI8226 cell lysate proteins were separated by SDS-PAGE and transferred to PVDF membranes. CDK8, CDK19 and b-actin (as a control) were detected by Western blotting using specific antibodies as indicated. (B) Knockdown efficiencies of si-CDK8 and/or si-CDK19 were also measured by RT-qPCR (n = 3). (C-F) Effects of CDK8 and/or CDK19 knockdown on expression of various genes. The expression level of each mRNA was measured by RTqPCR in control, CDK8, CDK19 and CDK8/19 double-knockdown cells treated with 1 lM ODN2006 for 3 h (n = 3). The data were normalized by defining the level of signal without ODN2006 treatment as 1. The error bars show SD, *P < 0.05; **P < 0.01; ***P < 0.001.
histone lysine methyltransferase EZH2, which mediates trimethylation of histone H3 lysine 27, regulates neural differentiation (Fukasawa et al. 2015) . EZH2 is a component of polycomb repressive complex 2 (PRC2), which regulates cell development and differentiation through transcriptional repression (Kuzmichev et al. 2002; Shen et al. 2008; Morey & Helin 2010) . To explain mechanisms underlying CDK8/19-mediated transcriptional activation of inflammatory gene upon TLR9 stimulation, we showed that dissociation of PRMT5 and/or PRC2 from CDK8/19 causes transcriptional activation of target genes of NF-jB and C/EBPb upon TLR9 stimulation according to our previous results (Furumoto et al. 2007; Tsutsui et al. 2008) . However, ChIP assays with anti-PRMT5 and anti-EZH2 Relative chip signal IP: Pol II P E P E P E *** DDW ODN2006 ODN2006GC P E P E P E DDW ODN2006 ODN2006GC P E P E P E DDW ODN2006 ODN2006GC P E P E P E DDW ODN2006 ODN2006GC P E P E P E DDW ODN2006 ODN2006GC P E P E P E DDW ODN2006 ODN2006GC P E P E P E DDW ODN2006 ODN2006GC P E P E P E DDW ODN2006 ODN2006GC P E P E P E DDW ODN2006 ODN2006GC P E P E P E DDW ODN2006 ODN2006GC P E P E P E DDW ODN2006 ODN2006GC P E P E P E DDW ODN2006 ODN2006GC Figure 4 Localization of CDK8 and/or CDK19, C/EBPb, NF-jB and Pol II on inflammatory genes. Occupancies on the promoter (P) and exon (E) regions of IL8 (A), IL10 (B) and PTX3 (C) genes were measured by ChIP with the indicated immunoprecipitation (IP) antibodies, followed by qPCR (n = 3). Schematic gene structures are shown above the corresponding panels. ODN2006 treatment was carried out at 1 lM for 3 h. The data were normalized by defining the signal level from cells treated with double-distilled water (DDW) of the promoter regions as 1. The error bars show SD, *P < 0.05; **P < 0.01; ***P < 0.001.
Genes to Cells (2017) 22, 265-276 antibodies were unable to detect PRMT5 and EZH2 at the promoters because of weak ChIP signals ( Fig. S2 in Supporting Information). So, we changed ChIP targets from modification enzymes to modified histones. Unfortunately, these ChIP assays also did not identify alterations in levels of acetylated and trimethylated H3K27 binding to cytokine genes on TLR9 stimulation (Fig. S3 in Supporting Information).
Discussion
In this study, we found that myeloma-derived RPMI8226 cells expressed high levels of human TLR1, TLR2, TLR4, TLR6, TLR8, TLR9 and TLR10 mRNAs (Fig. 1) , which was consistent with previously published results (Takeshita et al. 2004) . In these cells, our results showed that CDK8/19 activated inflammatory (and anti-inflammatory) gene expression in cooperation with major transcriptional activators NF-jB and C/EBPb upon TLR9 stimulation.
CDK8/19 localizes at inflammatory gene promoters and plays roles in transcriptional activation together with C/EBPb and NF-jB upon TLR9 stimulation
In TLR4 and TLR9 signaling, TLR4 recognizes bacterial lipopolysaccharide (LPS), whereas TLR9 recognizes unmethylated CpG DNA motifs that are frequently present in viral and bacterial DNAs (Kawai & Akira 2010 Figure 5 Localization of CDK8, CDK19, MED1, TFIIEa and TFIIB on inflammatory genes. Chromatin immunoprecipitation (ChIP) analyses of CDK8, CDK19, MED1, TFIIEa and TFIIB on the promoter (P) and exon (E) regions of IL8 (A), IL10 (B) and PTX3 (C) genes were measured by immunoprecipitation (IP) with the indicated antibodies, followed by qPCR (n = 3). The data were normalized by defining the signal level from cells treated with double-distilled water (DDW) of the promoter regions as 1. The error bars show SD, *P < 0.05; **P < 0.01; ***P < 0.001.
genes (Figs 2-4) . CpG-containing oligonucleotides activate NF-jB-responsive IL8 gene expression in RPMI8226 cells (Lee et al. 2004) . In addition to IL8, we found that CpG oligonucleotides activate transcription of other inflammatory (and anti-inflammatory) genes such as IL10, PTX3, CCL2, CCL3 and CCL4 (Fig. 2) . Similar to C-reactive protein and serum amyloid P, PTX3 is considered to be a biomarker for inflammation or infection (Bastrup-Birk et al. 2013; Liu et al. 2014) . Our results showed that CDK8/19 colocalizes with C/EBPb and NF-jB at inflammatory gene promoters and regulates their transcription positively (Figs 3,4) . (Bancerek et al. 2013) . CDK8/19 activation of transcription of inflammation-associated genes in cooperation with NF-jB and C/EBPb suggests a role of CDK8/19 in inflammation as illustrated in Fig. 6 .
Involvement of CDK8/19 in transcriptional activation on TLR9 stimulation
CDK8/19 has previously been shown to dissociate from the IL8 promoter on PMA treatment of HeLa cells (Tsutsui et al. 2013) , whereas our present results have showed that CDK8/19 accumulates on the promoters of inflammation-associated genes such as IL8, IL10 and PTX3 on TLR9 stimulation in RPMI8226 cells. In comparison with the direct activation of NFjB upon TLR9 stimulation, PMA might affect various transcription factors through activation of protein kinase C, resulting in crosstalk with NF-jB and C/ EBPb signaling, and affecting expression of IL8. In addition, association of CDK8/19 with chromatinremodeling factors such as PRMT5 and EZH2 might vary in different cells, and these interactions might affect transcriptional regulation.
PRMT5, EZH2 and modification of histone H3K27 may not contribute to the effects of TLR9 stimulation
In our initial hypothesis, CDK8/19-bound PRMT5 and EZH2 (which repress transcription through histone modification) would dissociate from inflammation-associated gene promoters after dissociation from CDK8/19 stimulated by TLR9. CDK8/19-containing Mediator phosphorylates threonine 492 (Thr492) on EZH2, which destabilizes association of EZH2 with PRC2 (Zeng et al. 2011) , and may cause dissociation of PRC2 from the promoter, leading to transcriptional activation. However, our results did not indicate whether PRMT5 and EZH2 remained on the gene promoters together with CDK8/19 (Fig. S2 in Supporting Information). PRMT5 activates NF-jB by arginine methylation of the p65 subunit (Wei et al. 2013; Harris et al. 2014) . In experiments with MDA-MB231 cells, EZH2 was shown to localize adjacent to the promoter during IL6 expression (Ndlovu et al. 2009) . These data indicate that transcription is not activated or repressed solely by histone modifications, but is regulated through complicated interactions of transcription factors, Mediator and chromatin-regulatory factors. Histone H3K27 trimethylation is known to cause inactivation of gene promoters, whereas H3K27 acetylation is associated with transcriptional activation (Cao et al. 2002; Barski et al. 2007; Tie et al. 2009; Ferrari et al. 2014) . Our results identified no significant changes in histone H3K27 modifications in RPMI8226 cells on treatment with ODN2006 ( Fig. S2 in Supporting Information), which could indicate that modified H3K27 was present at the inflammatory gene promoters in unstimulated RPMI8226 cells. TLR9 stimulation might then induce cytokine-gene transcription through Genes to Cells (2017) 22, 265-276 transcriptional activators and Mediator without further histone modifications.
CDK8/19 regulates TLR9-mediated inflammation
In a study of acute myeloid leukemia, CDK8/19, MED1 and bromodomain-containing protein 4 (BRD4) regulated gene expression through binding to super-enhancers (Pelish et al. 2015) . Mediator including CDK8 associates with GCN5L acetyltransferase together with TRRAP polypeptide and acetylates histone H3K14 cooperatively for transcriptional activation (Meyer et al. 2008) . In a study involving the selective CDK8/19 inhibitor cortistatin A, CDK8/19 affected pathways implicated in inflammation, growth and metabolic regulation (Poss et al. 2016) . Our results have now showed that CDK8/19 positively regulates transcription of inflammationassociated genes in cooperation with NF-jB and C/ EBPb upon TLR9 stimulation. Mediator containing CDK8/19 might regulate transcription positively and negatively through alteration in the affinities of transcription factors, Mediator and chromatin-modification factors in response to cellular stimulation.
CDK8 is widely conserved from yeast to humans, whereas CDK19 is conserved only in vertebrates (Tsutsui et al. 2008) , suggesting the possibility that CDK8 is essential for cell proliferation, whereas CDK19 is involved in cell differentiation. Our results showed that CDK8/19 activates expression of inflammation-associated genes. Results from previous studies showed associations of CDK8/19 with cell differentiation and cancer development through regulation of transcription of various genes. Histone modifications might determine whether CDK8/19-mediated transcriptional regulation involves activation or inactivation. Continuous studies of Mediator kinase activity would clarify the roles of Mediator kinases in transcriptional regulation.
Experimental procedures
Cell lines and stimulation by TLR9 agonist RPMI8226, Jurkat and HEK293 cells were seeded at 6 9 10 6 cells per 6-cm dish, suspended in RPMI1640 medium supplemented with 10% calf serum and cultured at 37°C in an atmosphere containing 5% CO 2 . Phosphorothioate-modified ODN2006 (containing CpG sequence; 5 0 -tcgtcgttttgtcgttttgtcgtt-3 0 ) and ODN2006GC (NTC for ODN2006 with GpC sequence; 5 0 -tgctgcttttgtgcttttgtgctt-3 0 ) were synthesized by Gene Design (Osaka, Japan). For ODN2006 treatment, RPMI8226
and Jurkat cells were cultured with 1 lM oligonucleotides for 3 h at 37°C. After incubation, these cells were harvested and total RNA was extracted and purified on an RNeasy column (Qiagen, Cambridge, MA, USA).
RT-qPCR
RT-qPCR was carried out by One Step SYBR â PrimeScript TM RT-PCR Kit (TaKaRa, Shiga, Japan) with 10 ng of total RNA and quantified using the Mx3005P QPCR system (Agilent, Santa Clara, CA, Japan). QPCR human reference total RNA (Agilent), which was composed of total RNA from 10 human cell lines, was used as a calibrator for RT-qPCR.
siRNA-mediated knockdown of gene expression
Validated siRNAs designed to knock down the endogenous expression of CDK8/19, and scrambled siRNA as a control, were purchased from Santa Cruz. siRNAs against CDK8/19 or scrambled siRNA was transfected at 5 nM by an electroporation method. At 24 h after transfection, cells were washed with growth medium and cultured for an additional 48 h before harvest, and then subjected to further analyses.
Chromatin immunoprecipitation (ChIP)
ChIP assays were carried out using Magna ChIP G kit (Merck Millipore, Watford, UK) according to the manufacturer's protocol. RPMI8226 cells grown in 6-cm dishes were stimulated with ODN2006 for 3 h and fixed in 1% formaldehyde for 10 min at room temperature. Chromatin was sheared by sonication to give fragments 250-1000 bp in length. ChIP was carried out overnight at 4°C with 2 lg of the indicated antibodies. Immunoprecipitated DNA fragments were amplified by real-time PCR. The ChIP results were presented as relative ChIP signal with respect to cells without ODN2006 treatment (designated as having a ChIP signal of 1).
Antibodies
The antibodies used in this study were as follows: antihuman C/EBPb rabbit polyclonal (sc-150; Santa Cruz Biotechnology), anti-human CDK8/19 goat polyclonal (sc-1521; Santa Cruz Biotechnology), anti-human CDK8 mouse monoclonal (552053; BD Biosciences, San Jose, CA, USA) for Western blotting, anti-human CDK19 rabbit polyclonal (HPA007053; Sigma-Aldrich, St Louis, MO, USA), antihuman Pol II rabbit polyclonal (sc-899; Santa Cruz Biotechnology), anti-human NF-jB p65 rabbit polyclonal (ab7970; Abcam, Cambridge, MA, USA), anti-human TFIIEa rabbit polyclonal (sc-237; Santa Cruz Biotechnology), anti-human TFIIB rabbit polyclonal (sc-225; Santa Cruz Biotechnology), anti-MED1 rabbit polyclonal (ab60950; Abcam), anti-normal rabbit IgG (nIgG) (sc-2027; Santa Cruz Biotechnology), antihuman PRMT5 rabbit polyclonal (07-405; Merck, Watford, UK), anti-human EZH2 rabbit polyclonal (SAB1410354; Sigma-Aldrich), antihistone H3 (acetyl K27) rabbit polyclonal (ab4729; Abcam), antihistone H3 (tri methyl K27) mouse monoclonal (ab6002; Abcam). Anti-human CDK8 polyclonal antibody for ChIP assay was raised in rabbits using bacterially expressed recombinant CDK8.
Expression and purification of recombinant histagged hCDK8 and hCDK19
Recombinant his-tagged hCDK8 and hCDK19 proteins were expressed in the Escherichia coli Rosetta TM (DE3) pLysS expression strain (Novagen) by induction with isopropyl-b-D-thiogalactopyranoside (IPTG) and were purified by Ni-NTA agarose (Qiagen).
Primer sets for qPCR
The primers for RT-qPCR analysis and ChIP analysis are listed in Table 1 . 
